These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 7487936)

  • 1. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
    Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
    J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
    Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
    J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain.
    Torre-Blanco A; Adachi E; Romanic AM; Prockop DJ
    J Biol Chem; 1992 Mar; 267(7):4968-73. PubMed ID: 1537873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.
    Bateman JF; Chan D; Walker ID; Rogers JG; Cole WG
    J Biol Chem; 1987 May; 262(15):7021-7. PubMed ID: 3108247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
    Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
    J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions for arginine at position 780 in triple helical domain of the α1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta.
    Makareeva E; Sun G; Mirigian LS; Mertz EL; Vera JC; Espinoza NA; Yang K; Chen D; Klein TE; Byers PH; Leikin S
    PLoS One; 2018; 13(7):e0200264. PubMed ID: 29990383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
    Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
    J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
    Kadler KE; Torre-Blanco A; Adachi E; Vogel BE; Hojima Y; Prockop DJ
    Biochemistry; 1991 May; 30(20):5081-8. PubMed ID: 2036375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
    Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
    J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gly802Asp substitution in the pro alpha 2(I) collagen chain in a family with recurrent osteogenesis imperfecta due to paternal mosaicism.
    Lund AM; Schwartz M; Raghunath M; Steinmann B; Skovby F
    Eur J Hum Genet; 1996; 4(1):39-45. PubMed ID: 8800927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
    Raghunath M; Bruckner P; Steinmann B
    J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
    Cabral WA; Chernoff EJ; Marini JC
    Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta.
    Forlino A; Keene DR; Schmidt K; Marini JC
    Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of arginine for glycine at position 847 in the triple-helical domain of the alpha 1 (I) chain of type I collagen produces lethal osteogenesis imperfecta. Molecules that contain one or two abnormal chains differ in stability and secretion.
    Wallis GA; Starman BJ; Schwartz MF; Byers PH
    J Biol Chem; 1990 Oct; 265(30):18628-33. PubMed ID: 2211725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.
    Valli M; Sangalli A; Rossi A; Mottes M; Forlino A; Tenni R; Pignatti PF; Cetta G
    Eur J Biochem; 1993 Feb; 211(3):415-9. PubMed ID: 7679635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
    Tsuneyoshi T; Westerhausen A; Constantinou CD; Prockop DJ
    J Biol Chem; 1991 Aug; 266(24):15608-13. PubMed ID: 1874719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
    Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
    Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
    Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
    Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.